Navigation Links
Neurotoxins might Reverse Mononeuronal Disease – Study Find

By making modifications in botox – an anti-wrinkle treatment, Dr Frederic Meunier, a winner of UniQuest's 2006 competition has developed a cure for motoneuronal diseases//.

Researcher used neurotoxins to form a selective motoneuron delivery system in the body, which blocked the unnecessary neuronal communications and thus assists in treating the motorneuron diseases.

Motoneuronal diseases cause a degeneration of the nerve pathways controlling muscle activity. The diseases are severe and physically debilitating disorders, which lead to progressive weakness and wasting of muscles. Many of the diseases are incurable.

Dr Meunier is developing botox to selectively deliver drugs to motoneurons to directly treat motorneuron diseases.

‘I first became interested in investigating neurotoxins because they are fantastic molecular tools to dissect synaptic mechanisms,’ Dr Meunier said.

‘The aim of our lab is to understand the molecular mechanism underlying neuronal communication. The legacy of millions of years of evolution and competition between venomous species has resulted in deadly neurotoxins capable of blocking neuronal communication. I am using our knowledge of the mode of action of these neurotoxins to design a selective motoneuron delivery system that could change our way of treating motoneuronal diseases.’

Dr Meunier's innovative research caught the attention of UQ's main commercialisation company, UniQuest Pty Ltd, which runs the annual Trailblazer competition.

UniQuest Managing Director David Henderson said the Trailblazer judges were impressed by Dr Meunier's research and the opportunities surrounding it.

‘The therapeutic applications of this research are important, as it could help prevent or cure motoneuronal diseases,’ Mr Henderson said.

‘Also, the research potentially has important applications for the treatment of other diseases.’

Source: Eurkalert
'"/>




Page: 1

Related medicine news :

1. Suicide might be inherited
2. Cleanliness might lead to Asthma
3. Stroke risk might be linked to antibody
4. Change in walking might indicate Dementia
5. Drug might prevent Prostate Cancer Spread
6. Diet might just have an Effect on Breast Cancer
7. Chlorine might be a cause for Asthma
8. Pill might be able to reduce the damage loud noise does to your hearing
9. Drug might prevent Prostate Cancer Spread
10. Women might be at increased risk of HIV during pregnancy
11. Older generation might pose a threat to increase the NHS budget
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of ... Philippines. “The Journey: From the Mountains to the Mission Field” is the creation of ... taught all ages and currently teaches a class of ladies at her church, which ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco dentists, ... cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated to ... breathing. Oral appliances can offer significant relief to about 75 percent of people ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( ... today the introduction of an innovative new design of the shoulder pad. The ... get maximum comfort while controlling your pain while using cold therapy. By utilizing ice ...
(Date:10/12/2017)... Maryland (PRWEB) , ... October 12, 2017 , ... ... magnetic drug delivery system that we intend to develop to enable prevention of ... can lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing ...
(Date:10/12/2017)... ... ... Leading pediatric oncology experts at Children’s National Health System will join ... International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by Jeffrey Dome, ... at Children’s National, and Stephen P. Hunger, M.D., Chief of the Division of ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... 25, 2017  EpiVax, Inc., a leader in ... immune-engineering today announced the launch of EpiVax Oncology ... personalized therapeutic cancer vaccines. EpiVax has provided $500,000 ... to enabling technologies to the new precision immunotherapy ... EpiVax Oncology as Chief Executive Officer. Gad brings ...
(Date:9/19/2017)... Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, ... tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek , PhD, ...
(Date:9/13/2017)... 13, 2017   OrthoAtlanta has been named the ... Host Committee (AFHC) for the 2018 College Football Playoff (CFP) ... at Mercedes-Benz Stadium in Atlanta, Georgia . ... "I,m In" campaign, participating in many activities leading up to, ... ...
Breaking Medicine Technology: